Solitary fibrous tumors (SFTs) are rare soft-tissue sarcomas usually arising in the pleura of the thoracic cavity. Thirty percent of SFTs present in extrapleural locations, and infrequently in the head and neck region. While the majority of SFTs are benign, aggressive variants have been described. We report a case of a patient with a malignant SFT arising in the suboccipital soft tissues of the neck. We elucidate the diagnostic and therapeutic challenges in managing this tumor in this unusual location.
Introduction
Solitary fibrous tumors (SFTs) are rare soft-tissue sarcomas first described as arising from the pleura in 1931 by Klemperer and Rabin. 1 Extrapleural SFTs account for 30% of cases, and some large case series have found only 6% arising in the head and neck. 2 Malignant SFTs (MSFTs) of the head and neck region are very unusual and have been described as most often arising on mucosal surfaces or superficial soft tissue. 3 We report a case of a patient who presented with a growing recurrent mass in the soft tissues of the left suboccipital posterior neck that was diagnosed as MSFT only after previous resection of a mass that was thought to be a benign hemangiopericytoma (HPC).
Case report
A 64-year-old Korean woman presented with a growing subcutaneous mass in the left suboccipital region. She had a history of a previous resection in the same location of a tumor that had been diagnosed as an HPC 5 years earlier at an outside hospital. The patient received no further therapy after the initial resection.
On physical examination, a 50-mm, indurated, subcutaneous mass was palpated in the suboccipital region of the posterior neck. Magnetic resonance imaging (MRI) revealed a well-circumscribed, 50 × 37 × 34-mm softtissue mass in the posterior neck-close to the skull base, posterior to the foramen magnum, and extending to the level of the C1 vertebra (figure 1). The lesion appeared iso-to hyperintense on STIR MRI imaging, and hypointense on T1-weighted MRI. On computed tomography, the mass appeared to be displacing the paraspinal musculature. No evidence of intracranial or pulmonary disease was seen on complementary imaging studies.
The mass was surgically removed and measured 60 mm in diameter. On H&E-stained sections, the tumor was found to be hypercellular with a sheet-like growth pattern and a relatively discrete border. It was composed of round to spindle-shaped cells with abundant intervening collagen. Dilated "staghorn" vessels, characteristic of SFT, were present (figure 2, A). On high-power magnification, the tumor showed moderate nuclear pleomorphism with numerous mitotic figures. The mitotic figures were quantitated at 7 per 10 high-power fields ( figure 2, B ). The tumor showed strong immunoreactivity for CD34 and weak immunoreactivity for Bcl-2. Immunostains for S-100 protein were only focally positive. The tumor was negative for actin, desmin, and cytokeratins. Taken together, these findings are representative of an MSFT.
The patient received postoperative radiation accompanied by close clinical follow-up. Three years after surgery, the patient remained disease-free.
Discussion
SFT is an uncommon soft-tissue sarcoma usually located in the thoracic cavity. 2 hypercellular and hypocellular areas separated from each other by dense collagen. The hypercellular areas are composed of round to spindle-shaped cells with a fascicular, storiform, or fibrosarcoma-like arrangement, and multiple ramified vessels with thick hyalinized walls. 4 The criteria for diagnosis of MSFT includes increased cellularity, a sheet-like growth pattern without areas of alternating hypocellularity or sclerosis, and more than 4 mitoses per 10 high-power fields. Some authors have associated necrosis and a tumor size greater than 10 cm with a poor prognosis. 2 Interestingly, Cox et al found that recurrent head and neck SFTs are more often associated with incomplete resection (i.e., failure to achieve clear microscopic negative margins) than to microscopic grade. 8 While extrathoracic SFTs are generally considered benign, Yang et al quote a locoregional recurrence rate ranging between 25 and 50% and a distant metastasis rate of 10 to 60% for MSFT. 6 They also found in their own series of head and neck MSFTs a distant metastasis rate of 33%. 6 Historically, the primary differential diagnosis for SFT included HPC, as the two lesions were described as two separate entities; however, current convention supports the notion that these tumors represent a spectrum of related neoplasms. For instance, SFTs show great histologic variability, and Gengler and Guillou described five different variants: fibrous, cellular, fat-forming, to the pleura, extrapleural SFTs have been reported in basically every anatomic location. 4 However, SFTs of the head and neck are very rare, and predominantly benign. 5 The few MSFTs diagnosed in the head and neck have presented primarily on mucosal surfaces or superficial soft tissues, including the cheek, paranasal sinus, nose, oral cavity, jaw, parotid gland, and orbital region. 3, [5] [6] [7] [8] In the present case, the tumor affected the deep soft tissue in the left suboccipital region. To our knowledge, this is the first instance of MSFT in this location reported in the United States, and this report draws attention to the potential for MSFTs to occur at this site. Of note, in Germany, Wilde et al previously reported a series of 2 MSFTs, one of which was found in a similar location. 7 SFTs can occur at any age during adulthood and show no sex predilection. 2, [4] [5] [6] They usually present as well-circumscribed, partially encapsulated neoplasms. They are generally slow-growing but can reach a size greater than 100 mm, producing symptoms due to mass effect. 4 Extrathoracic SFTs are more likely to produce these compressive symptoms. 2 Imaging studies reveal SFTs as partially encapsulated soft-tissue masses. 6 MRI demonstrates the mass as isointense to brain on precontrast T1-and T2-weighted images, sometimes with heterogenic hyperintense areas in the T2-weighted images. 5 Microscopically, SFTs are characterized by alternating giant-cell-rich, and fibrous histiocytoma. 4 Highly cellular neoplasms containing cells resembling the so-called "pericyte" are now classified as cellular SFTs rather than HPCs. 4 An exception to this newer convention occurs in the central nervous system, where the distinction between SFT and HPC is retained. 9 Other soft-tissue tumors found in the head and neck include benign neural tumors, synovial sarcoma, sarcomatoid carcinoma, solitary myofibroma, and other entities that recently have been described, such as giant-cell angiofibroma, and nuchal-type fibroma. 10, 11 Immunohistochemistry plays an important role in differentiating SFTs from other tumors, as they commonly express CD34 and CD99, and they may also stain for Bcl-2. SFTs show variable staining with epithelial membrane antigen and, in 20% of cases, smooth muscle actin. 4 In addition, SFTs are usually negative for S-100 protein and cytokeratins, helping to distinguish them from benign neural tumors, synovial sarcoma, and sarcomatoid carcinoma. 4, 6 The treatment of choice for MSFT is surgical resection, and when complete resection cannot be achieved with negative margins, or the patient history suggests a greater risk for recurrence (e.g., tumor size greater than 50 mm), postoperative radiation therapy is recommended. 6, 8 Controversy exists about the effectiveness of chemotherapy in unresectable MSFT. 6 Better outcomes are expected for smaller tumors, and resectability is the most important prognostic factor. 5, 8 Our patient received postoperative radiation therapy after surgery because of her previous unsuccessful surgery and the size and histologic features of the tumor, as well as the uncertainty of having achieved clear resection margins. She has been disease-free for 3 years.
In conclusion, MSFTs of the head and neck are very rare and can pose a diagnostic dilemma when they occur in the deep tissues of the neck. They should be treated with surgery followed by radiation therapy when indicated. 
